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Abstract
Background: Gastro-oesophageal reflux disease (GORD) is a long-term complication of achalasia treatments. The aim of our
study was to evaluate the yield of prolonged wireless pH monitoring in patients with successfully treated achalasia and its
influence on proton pump inhibitor (PPI) use.
Methods: Twenty-five patients with achalasia who underwent prolonged wireless pH monitoring after a successful treatment
with pneumatic dilation were enrolled. pH variables were analysed in the first 24 hours of monitoring to determine if
tracings were indicative of GORD; the same variables were analysed in the following 24-hour period in order to obtain a
worst-day diagnosis of GORD. PPI therapy before and after the test was recorded.
Results: Five out of 25 patients had GORD diagnosis during the first day of monitoring and four of them had oesophagitis at
endoscopy. During the following days of monitoring four more patients had a diagnosis of GORD. Out of the 25 patients, PPIs
were started after the test in six asymptomatic GORD-positive ones, whereas prescription of PPIs was stopped without
detrimental effect on symptoms in three GORD-negative patients.
Conclusions: Prolonged wireless pH monitoring is a useful test to be added to endoscopy in order to evaluate GORD and to
optimise antisecretory treatment in successfully treated achalasia patients.
Keywords
Prolonged wireless pH monitoring, gastro-oesophageal reflux disease, achalasia, pH-metry, oesophagus
Received: 25 August 2016; accepted: 6 November 2016
Introduction
Oesophageal achalasia is a rare disease characterised by
impaired relaxation of the lower oesophageal sphincter
(LOS) and loss of normal peristalsis in the oesophageal
body.1 All available treatments (i.e. pneumatic dilation
(PD), Heller myotomy (HM) and more recently per-oral
endoscopic myotomy (POEM)) aim to disrupt the LOS
and reduce its pressure in order to allow oesophageal
emptying.2 Gastro-oesophageal reﬂux disease (GORD)
may occur as a complication. Studies with 24-hour pH
monitoring have shown increased oesophageal acid
exposure time (AET) in a variable percentage of patients
treated with PD, HM with or without anti-reﬂux pro-
cedure and POEM, ranging from 4.7% to 53%.3–6
However 24-hour reﬂux tests have some intrinsic limita-
tions such as physiological day-to-day variability of
oesophageal AET due to diﬀerent daily dietary habits
and physical activity.7–9 These limitations could be
particularly relevant in achalasia patients in whom
reﬂux is characterised by a few long-lasting epi-
sodes.3,10,11 Thus, studies with 24-hour pH monitoring
could have underestimated prevalence of pathological
GORD in this particular population similarly to what
has been shown in patients with GORD.12–14 Although
it could be argued that presence of post-treatment
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GORD can be evaluated with symptoms (heartburn,
chest pain, regurgitation) and need for proton pump
inhibitors (PPIs),5,15 a purely symptomatic approach
has limitations because on one hand achalasia patients
have alterations in sensory neural pathways16–18 and
may have a higher threshold for perception, and on
the other symptoms may not be related to GORD with
consequent misuse of PPIs.4,19,20
The Bravo wireless technique has been developed in
order to overcome limitations of traditional catheter-
based pH testing. In non-erosive reﬂux disease patients
(NERD) prolonged wireless pH monitoring has been
shown to diagnose GORD in those with a normal AET
during the ﬁrst 24 hours of monitoring or with previously
negative 24-hour catheter-based monitoring.13,14
Moreover, one recent study regarding an achalasic
cohort treated with POEM21 evaluated reﬂux after the
endoscopic treatment with prolonged wireless pH moni-
toring and showed a higher incidence of reﬂux (58%)
compared to a review of previous studies6 in which 24-
hour pH monitoring was used. However, this study did
not formally assess if the likelihood of GORD detection
was higher when pH monitoring covers more days.
Furthermore, to our knowledge no studies have evaluated
the prevalence of GORD in achalasia patients treated
with PD using prolonged wireless pH monitoring.
The aim of our study was to evaluate the yield of
prolonged wireless pH monitoring in GORD diagnosis
in a cohort of achalasia patients successfully treated
with PD and its inﬂuence on PPI use.
Methods
Study population
Twenty-ﬁve consecutive achalasia patients (12 males;
47 years of age; 38–63) who underwent prolonged wire-
less pH monitoring after a successful treatment with
single or multiple PD were reviewed from our cohort
of patients and included in the study. Treatment was
deﬁned successful if stable clinical remission was
achieved (Eckardt score 3 evaluated at three and 12
months after dilation).3 In our centre additional criteria
for success are a negative intraoesophageal pressure at
oesophageal high-resolution manometry (HRM) at
three and 12 months and a decrease in the maximum
diameter of the middle third of the thoracic oesophagus
compared with pre-treatment at barium oesophago-
gram 12 months after dilation. Both additional criteria
were present in all our 25 patients.
Ninety-six-hour wireless pH monitoring
After external calibration in buﬀer solutions pH 1.0
and 7.0, the Bravo pH capsule (Medtronic Inc,
Shoreview, MN, USA) was attached 6 cm above the
squamocolumnar junction during upper endoscopy
under mild conscious sedation (1–5mg midazolam
intravenously (i.v.)) as previously described.22 pH
monitoring was then activated and data were stored
in the receiver for 48 hours. During the pH study
patients were encouraged to engage in their usual
activities including work and exercise with the only
restriction that no sipping of acidic beverages (e.g.
orange juice, cola) occur between meals so as not
to alter readings. They were asked to press the
event marker button on the receiver whenever they
experienced their symptoms. Furthermore, patients
kept diaries documenting timing of food intake,
change of posture and occurrence of symptoms
according to their watch, which was synchronised
with the Bravo receiver. After 48 hours of pH rec-
ording, patients returned to the hospital and gave
receivers and diaries back. Recorded data were down-
loaded to a computer using commercial software
(Polygram Net, Medtronic, Denmark), and patients
were invited to participate in a second 48-hour rec-
ording. Antisecretory drugs (PPIs) were stopped at
least eight days before pH monitoring; patients were
instructed not to use antacid formulations during the
whole recordings.
Oesophageal manometry
HRM (Solar HRM, MMS, the Netherlands) was
performed in all patients before prolonged wireless
pH monitoring using a disposable 20-sensor cath-
eter (MMS G-90500). The oesophageal manometry
catheter was passed trans-nasally under topical
anaesthesia (Lidocaine spray 10%) after an over-
night fast, and positioned so that it straddled the
LOS. The whole test was performed with the
patients in a recumbent position on their right
side. The information obtained with a standard
manometric protocol included baseline tone of the
LOS (recorded for at least 30 seconds) and intraoe-
sophageal pressure.
Outcome evaluation
At our Gastrointestinal Unit patients with oesophageal
disorders undergo a standardised medical interview
during patient evaluation.22,23 Patient outcome data
were obtained by reviewing hospital ﬁles with regards
to consultations which occurred before and after wire-
less pH monitoring. Regarding treatment for GORD,
information was sought on PPI treatment before wire-
less pH monitoring and whether the treatment was
stopped/continued after the test and during the
follow-up period.
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Data analysis
pH variables were analysed in the ﬁrst 24-hour periods
in order to determine if tracings were diagnostic of
GORD: percentage of time at pH <4 more than
4.7%24 and/or positive symptom index (SI) or symp-
tom association probability (SAP). Number of reﬂux
episodes were considered increased if >57/24 hours.24
The same variables were analysed in the following
24-hour periods in order to obtain a worst-day diagno-
sis of GORD. Moreover, SI and SAP were measured
during the whole period of monitoring. Furthermore,
percentage time at pH< 4 in upright and supine pos-
ition and number of long-lasting episodes of reﬂux
(>5min) were calculated in tracings of patients. In
order to exclude intraoesophageal acidiﬁcation due to
fermentation, tracings were manually scanned in order
to detect slow steady drops of pH not reaching values
below 3 and exclude them from AET calculations.4,25
Only days with at least 21-hour recordings were
included.
In the outcome analysis, patients were considered
GORD positive or negative both according to wireless
pH monitoring and endoscopy.
Data were expressed as median (ﬁrst and third quar-
tile). Non-parametric statistics and chi-square test were
used when appropriate.
Results
Wireless pH monitoring was performed after at least
one year of clinical well-being from PD. Oesophagitis
was found in seven patients (three grade A, three grade
B and one grade C). No complications occurred during
upper endoscopy and wireless capsule positioning.
All patients (N¼ 25) reported normal activities of
daily living during wireless pH study and completed
at least 48 hours of monitoring; 13 patients decided
to stop registration at 48 hours because they were
living at quite a distance from our hospital. Of the
remaining 12 patients who agreed to undergo the
second 48-hour recording, capsule detachment
occurred on the third day in four and on the fourth
day in one, thus in seven patients pH monitoring
lasted 96 hours. No further dilation was needed
during the follow-up after wireless pH monitoring.
Impact of prolonged wireless pH monitoring on
GORD diagnosis
Characteristics of achalasia patients divided according
to worst-day GORD diagnosis at prolonged wireless
pH monitoring are described in Table 1. The two
groups were similar with regards to clinical and
manometric features. As depicted in Figure 1 ﬁve
out of the nine GORD-positive patients had GORD
diagnosis during the ﬁrst day of monitoring; four of
them had oesophagitis at endoscopy. Prolonging the
monitoring over the ﬁrst day, four more patients had
a worst-day diagnosis of GORD: Two during the
second day, one during the fourth day and one
during both the second and the fourth day of moni-
toring; two out of these four patients had oesopha-
gitis at endoscopy. All these patients received a
GORD diagnosis based on percentage of time at
pH< 4, whereas in the eight patient reporting symp-
toms during the monitoring (six had heartburn and
two had chest pain), two with increased and six with
normal AET, SI and SAP were negative both during
each 24 hours and the whole period. Only one patient
with negative prolonged wireless monitoring had
oesophagitis. No pH drops indicative of fermentation
were present in any patient.
Considering GORD-positive patients according to
pH monitoring, six out of nine showed isolated patho-
logical supine AET, whereas one patient had patho-
logical AET both in upright and supine periods, and
isolated pathological upright AET was seen in the
remaining two patients. Of note, in ﬁve patients patho-
logical supine values were seen during only one day of
monitoring. In GORD-negative patients, on the con-
trary, only one had isolated pathological AET in the
Table 1. Clinical and manometric data divided according to worst-day GORD diagnosis at prolonged wireless pH monitoring.
GORD positive (9) GORD negative (16) p value
Age 43; 35–56 52; 39–64 0.36
Patients with oesophagitisa 6 (A¼ 2, B¼ 3, C¼ 1) 1 (A) 0.0007
Number of pneumatic dilation before pH monitoring 2; 1–2 2; 1–2 0.69
Interval between treatment and pH monitoring (months) 15; 13–31 14; 13–32 0.90
Follow-up time after pH monitoring (months) 22; 10–46 47; 35–56 0.07
Basal LOS pressure (mmHg) 6; 3–10 4; 3–7 0.55
Basal intra-oesophageal pressure (mmHg) 2; 7 to 2 4; 6 to 3 0.20
aIn brackets are number of patients divided according to grade of oesophagitis. Median: interquartile range (IQR); GORD: gastro-oesophageal reflux
disease; LOS: lower oesophageal sphincter.
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supine position with a percentage of pH< 4 over 24
hours of 4.5%.
Long-lasting episodes of reﬂux were seen in all
GORD-positive patients whereas number of reﬂux epi-
sodes per day were normal in all patients (Table 2).
Considering GORD-negative patients, number of
reﬂux was normal in all patients and only six showed
presence of long-lasting reﬂux but with a signiﬁcantly
lower duration compared to GORD-positive patients.
Outcome evaluation
Data are shown in Figure 2. Eight out of 25 patients
were taking PPIs before the test: Six patients had
GORD-like symptoms and two patients had dyspepsia.
The remaining patients were asymptomatic for GORD
like symptoms. Follow-up data are available in 24
patients because one was lost to follow-up after wireless
pH monitoring. With regards to the GORD-positive
group, in four symptomatic patients who were already
taking PPIs before the prolonged pH monitoring (two
twice daily (bid) and two at morning time), PPIs were
continued. In four asymptomatic patients with both
oesophagitis and pathological wireless pH monitoring,
PPIs were started after the test and continued until the
last follow-up (three at dinner time and one at morning
time). In two additional asymptomatic patients with
pathological wireless pH monitoring, PPIs were started
at morning time after the test. With regards to the
GORD-negative group, prescription of PPIs was
stopped in three patients without detrimental eﬀect on
symptoms whereas it was maintained in the remaining
one because he had dyspeptic symptoms.
Discussion
To our knowledge this is the ﬁrst study evaluating the
prevalence of GORD in patients treated with PD using
prolonged wireless pH monitoring. Prolonged pH
monitoring allowed us to diagnose GORD after the
ﬁrst 24 hours of monitoring in four patients and in
particular in two of them who had no oesophagitis at
endoscopy. It could be argued that during the day of
capsule positioning patients may have eaten and moved
less than during the following days because of the dis-
comfort of the endoscopy and/or sedation.
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Figure 1. Daily AET variability in the nine GORD-positive patients according to worst-day wireless pH monitoring data. Each line rep-
resents a patient. Pathological AET was seen beyond the first day in four patients.
AET: acid exposure time; GORD: gastro-oesophageal reflux disease.
Table 2. Pattern of reflux in achalasic patients divided according
to worst day GORD diagnosis at prolonged wireless pH monitoring.
GORD
positive (9)
GORD
negative (16) p value
Number of reflux episodes 12; 7–20 3; 1–5 0.0008
Number of long lasting
reflux episodes
5; 3–8 0; 0–1 0.0002
Duration of long-lasting
reflux episodes (min)
60; 54–75 19; 8–33 0.01
GORD: gastro-oesophageal reflux disease; median: interquartile range
(IQR).
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However, the literature looking at trends of AET
during days of prolonged pH monitoring has generally
reported similar AETs.22,26–29
Furthermore, capsule pH-monitoring has proved
useful for GORD management: In nine out of 25
patients (36%) PPI therapy was modiﬁed after the
test: In three patients PPIs were stopped because symp-
toms were not related to reﬂux and AET was normal
during the whole monitoring; in the other six patients,
although asymptomatic, PPIs were started because
oesophagitis was found at endoscopy or pathological
AET was detected at the wireless pH-monitoring. In
particular prolongation of pH monitoring allowed us
to stop PPI therapy with stronger certainty when AET
was normal. A negative single-day pH monitoring
could be interpreted as a false-negative result due to
AET day-to-day variability; indeed in a study compar-
ing traditional 24-hour pH monitoring and 24-hour
pH-multichannel intraluminal impedance (MII), phys-
icians continued to prescribe PPIs in 45%–50% of
their patients despite negative test results.23 Results on
patients’ management should be cautiously considered
due to the retrospective nature of our study; however,
clinical and PPI status information were obtained during
the consultations by standardised medical interview.22,23
Another consideration is that there are no data regard-
ing usefulness of lifelong PPIs in asymptomatic treated
achalasia patients with increased reﬂux at pH monitor-
ing, especially if they are young and endoscopy is nega-
tive for oesophagitis. It is our practice to discuss pros
and cons of continuous PPI treatment with our patients,
share the decision and check their upper gastrointestinal
tract with an endoscopy every three to ﬁve years inde-
pendently of being on long-term PPI or not.
In the present study AET variability was more pro-
nounced than previously observed in a cohort of endo-
scopy-negative patients with typical GORD
symptoms,14 probably because of a diﬀerent patho-
physiology of gastro-oesophageal reﬂux in achalasia,
as detailed below.3,10,11 Total number of reﬂux episodes
was normal in all patients and reﬂux episodes were long-
lasting, suggesting that the main pathophysiological dis-
turbance was delayed oesophageal clearance due to
altered motility of the oesophageal body as described
earlier by Benini et al.11 Some episodes lasted more
than one hour also in asymptomatic patients.
Furthermore, the majority of patients (seven of nine)
with pathological pH monitoring had abnormal acid
exposure in the supine position which was isolated in
six of nine patients; the importance of prolongation of
monitoring is underlined by the fact that ﬁve out of the
seven patients with pathological supine values had this
alteration during one day of monitoring only. These
observations allowed us to start PPIs in three patients
at dinner time for better acid inhibition during the night.
Theoretically intra-oesophageal acidiﬁcation in achala-
sia patients could be due to fermentation;4 however, this
was not the case in any of the patients’ reﬂux; this obser-
vation is in line with the clinical characteristics of our
patients who were all successfully treated with PD, had
negative intra-oesophageal pressure at the oesophageal
manometry and had no history of food regurgitation at
the preliminary evaluation.
Achalasia patients with reﬂux after treatment are
quite diﬀerent from patients with classic GORD also
in terms of both pathophysiology and genesis of
GORD-like symptoms. They have alterations of sen-
sory neural pathways,16–18 thus on one side reﬂux
Off PPI
Before After
GORD positive
patients
GORD negative
patients
On PPI morning On PPI evening On PPI BID
Figure 2. PPI treatment before and after evaluation in GORD-positive and -negative patients classified according to both wireless pH
monitoring and endoscopy.
PPI: proton pump inhibitor; GORD: gastro-oesophageal reflux disease.
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may not be perceived and on the other heartburn and
chest pain could be related to the neuropathy and not
to reﬂux. Furthermore, chest pain could be the result of
dysmotility or oesophageal distension and increased
intra-oesophageal pressure. In our study symptoms
reported by achalasic patients during pH monitoring
were not related to reﬂux, and increased AET remained
asymptomatic in all patients. This observation is in line
with previous studies in which no correlation between
symptoms and acid reﬂux was observed.4,21 For these
reasons prolongation of pH monitoring is useful in
order to increase the certainty of a negative/positive
symptom-reﬂux association, by having a higher
number of symptomatic episodes be evaluated.
In conclusion, prolonged wireless pH monitoring is a
useful test to be added to endoscopy in order to evalu-
ate GORD and to optimise antisecretory treatment in
successfully treated achalasia patients. We suggest its
use not only after pneumatic dilation, but also after
per oral endoscopic or surgical myotomy.
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